As Per Our Report, the Europe Cannabis Testing Market Size is valued at USD 292.58 Million in 2019 and estimated to be growing at a CAGR of 12.1%, to reach USD 517.93 Million by 2024 during the forecast period 2019 - 2024.
The growth of the European Cannabis Testing Market is primarily due to the government's funding of cannabis education for physicians and the growing demand for cannabis quality research activities.
Increasing use of cannabis in drug development, including the treatment of pain, increasing regulatory approval for medicinal cannabis products, and ongoing research and development activities are driving the Europe Cannabis Testing Market over the review period. Pharmaceutical companies need to conduct stringent government quality tests and raise awareness about cannabis through sports, conferences, and seminars before using them in medicinal products. Increasing research and development of new treatments for chronic diseases by large pharmaceutical companies, as well as increasing the use of recreational and personal cannabis, is also contributing to the growth of the regional cannabis testing market.
The high cost of building a cannabis testing facility for expensive equipment hampers the growth of the cannabis testing market in the European region. Also, the lack of a unified test standard further hinders the future growth of the cannabis test business.
In Europe Cannabis Testing Market significant market growth is expected during the forecast period. This may be due to new medical marijuana legislation and approval for a manufacturing license since March 2017. Also, the growing demand for medical marijuana by patients and prescribers is supposed to accelerate further the growth of the European market on a projected schedule. Cannabis also offers a unique opportunity where the healthcare system is in the development and modernization stage.
The Europe Cannabis Testing Market looks promising. However, the lack of unified industry standards and the high costs associated with laboratory analytical instruments for cannabis testing pose significant challenges to market development.
This research report is segmented and sub-segmented into the following categories:
Europe is the second-largest market in the world after North America. Ongoing legalization of cannabis in some regions for medicinal purposes and the rising number of road accidents under the intoxication of cannabis is likely to propel the growth of this market in the region.
Promising Companies leading the Europe Cannabis Testing Market Profiled in the Report Agilent Technologies, Inc., Shimadzu Corporation, Waters Corporation, PerkinElmer, Inc., AB SCIEX LLC, Millipore Sigma, Restek Corporation, LabLynx, Inc. (U.S.), Steep Hill Labs, Inc., PharmLabs, LLC, SC Laboratories, Inc., Digipath Labs, Inc., CannaSafe Analytics, and Accelerated Technology Laboratories, Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product & Software
5.1.1 Analytical Instruments
22.214.171.124 Chromatography Instruments
126.96.36.199.1 Liquid Chromatography
188.8.131.52.2 Gas Chromatography
184.108.40.206.3 Other Chromatography Instruments
220.127.116.11 Spectroscopy Instruments
18.104.22.168.1 Atomic Spectrometry Instruments
22.214.171.124.2 Mass Spectroscopy Instruments
126.96.36.199 Other Analytical Instruments
188.8.131.52 Sample Preparation Products
184.108.40.206 Standards and CRMS
220.127.116.11 Chromatography Columns
18.104.22.168 Supplies and Accessories
5.1.5 Y-o-Y Growth Analysis, By Product & Software
5.1.6 Market Attractiveness Analysis, By Product & Software
5.1.7 Market Share Analysis, By Product & Software
5.2 Testing Procedures
5.2.1 Terpene Profiling
5.2.2 Potency Testing
5.2.3 Residual Solvent Screening
5.2.4 Pesticide Screening
5.2.5 Genetic Testing
5.2.6 Heavy Metal Testing
5.2.7 Microbial Analysis
5.2.8 Y-o-Y Growth Analysis, By Testing Procedures
5.2.9 Market Attractiveness Analysis, By Testing Procedures
5.2.10 Market Share Analysis, By Testing Procedures
5.3 End Users
5.3.1 Cannabis Cultivators
22.214.171.124 Small-Scale Laboratories
126.96.36.199 Medium-Scale Laboratories
188.8.131.52 Large-Scale Laboratories
5.3.3 Drug Manufacturers & Dispensaries
5.3.4 Research Institutes
5.3.5 Y-o-Y Growth Analysis, By End Users
5.3.6 Market Attractiveness Analysis, By End Users
5.3.7 Market Share Analysis, By End Users
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
184.108.40.206 By Product & Software
220.127.116.11 By Testing Procedures
18.104.22.168 By End Users
6.1.4 Market Attractiveness Analysis
22.214.171.124 By Product & Software
126.96.36.199 By Testing Procedures
188.8.131.52 By End Users
6.1.5 Market Share Analysis
184.108.40.206 By Product & Software
220.127.116.11 By Testing Procedures
18.104.22.168 By End Users
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Agilent Technologies Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Shimadzu Corporation
8.3 Waters Corporation
8.4 PerkinElmer Inc.
8.5 AB SCIEX LLC
8.6 Millipore Sigma
8.7 Restek Corporation
8.8 LabLynx Inc. (U.S.)
8.9 Steep Hill Labs Inc.
8.10 PharmLabs LLC
8.11 SC Laboratories Inc.
8.12 Digipath Labs Inc.
8.13 CannaSafe Analytics
8.14 Accelerated Technology Laboratories Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures